Study: Weight-loss drug Wegovy cuts risk of heart attack and stroke by 20%

A new study from Novo Nordisk found its weight-loss drug Wegovy may have heart benefits in overweight or obese individuals who have cardiovascular disease but no history of diabetes. CBS News medical contributor and editor at large for Public Health at KFF, Dr. Celine Gounder, joins “CBS Mornings” to discuss.